Abstract

Matrix metalloproteinases release intact syndecan-1 ectodomains from the cell surface giving rise to a soluble, shed form of the proteoglycan. Although it is known that shed syndecan-1 controls diverse pathophysiological responses in cancer, wound healing, inflammation, infection, and immunity, the mechanisms regulating shedding remain unclear. We have discovered that the heparan sulfate chains present on syndecan core proteins suppress shedding of the proteoglycan. Syndecan shedding is dramatically enhanced when the heparan sulfate chains are enzymatically degraded or absent from the core protein. Exogenous heparan sulfate or heparin does not inhibit shedding, indicating that heparan sulfate must be attached to the core protein to suppress shedding. Regulation of shedding by heparan sulfate occurs in multiple cell types, for both syndecan-1 and syndecan-4 and in murine and human syndecans. Mechanistically, the loss of heparan sulfate enhances the susceptibility of the core protein to proteolytic cleavage by matrix metalloproteinases. Enhanced shedding of syndecan-1 following loss of heparan sulfate is accompanied by a dramatic increase in core protein synthesis. This suggests that in response to an increase in the rate of shedding, cells attempt to maintain a significant level of syndecan-1 on the cell surface. Together these data indicate that the amount of heparan sulfate present on syndecan core proteins regulates both the rate of syndecan shedding and core protein synthesis. These findings assign new functions to heparan sulfate chains, thereby broadening our understanding of their physiological importance and implying that therapeutic inhibition of heparan sulfate degradation could impact the progression of some diseases.

Highlights

  • Syndecan ectodomains shed by cells can enhance progression of cancer, inflammatory disease, and pathogen infection

  • We have discovered that the heparan sulfate chains present on syndecan core proteins suppress shedding of the proteoglycan

  • These results suggest that reducing the amount of heparan sulfate present on syndecan-1 enhances shedding of the proteoglycan

Read more

Summary

Background

Syndecan ectodomains shed by cells can enhance progression of cancer, inflammatory disease, and pathogen infection. Shedding of syndecan-1 occurs constitutively or can be accelerated in response to various agonists (e.g. growth factors, chemokines, microbial toxins, insulin, or cellular stress) These diverse stimuli set off a cascade of molecular events that include signal transduction, intracellular regulators, and, protease activity at the cell surface that cleaves the core protein and releases syndecan-1 [4, 5]. Heparan sulfate present on syndecan-1 acts to suppress shedding of the ectodomain, possibly by interfering with MMP-mediated cleavage of the core protein This suppression occurs in multiple cell types, in both human and murine species and for syndecan-4 as well as syndecan-1. We find that in response to enhanced shedding there is a dramatic increase in synthesis of the core protein of syndecan-1 These data provide new insight into a previously unknown role for the heparan sulfate chains of syndecans

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call